Neuroprotection
Издатель: Wiley · ISSN 27707296 · 21 статей
-
Celebrating 50 years of translational neuroscience in Kuopio
Neuroprotection, EarlyView.
-
Chronic high‐altitude exposure and intracerebral hemorrhage: A novel perspective from the vascular‐immune‐neuronal network
Abstract Intracerebral hemorrhage (ICH) under chronic high‐altitude exposure exhibits distinct epidemiological characteristics: higher incidence, younger age at onset, more severe perihematomal edema, and worse clinical outcomes....
-
Effectiveness and safety of efgartigimod in patients with anti‐NMDAR or anti‐LGI1 encephalitis and its 18F‐DPA714 PET imaging evaluation: A multicenter, single‐arm, prospective, observational real‐world study
Abstract Background Efgartigimod disrupts the recycling of pathogenic IgG autoantibodies and may represent a candidate therapy for autoimmune encephalitis. This real‐world study evaluated the clinical efficacy, safety, and impact of...
-
Repurposing antimicrobial agents for neuroprotection: Mechanisms, clinical potential, and challenges
Abstract Antimicrobial agents, originally developed for infectious diseases, have become attractive candidates for repurposing in neurodegenerative and neuroinflammatory diseases owing to their anti‐inflammatory, antioxidant,...
-
Noninvasive or minimally invasive neuromodulation in animal models of acute ischemic stroke: A systematic review and meta‐analysis
Abstract Background Neuromodulation therapy has emerged as a potential brain cytoprotective strategy in the hyperacute phase of ischemic stroke (IS). This systematic review aimed to evaluate the cytoprotective effects of neuromodulation...
-
Mesenchymal stem cells as cellular factories for targeted P2X7 blockade after traumatic brain injury
Abstract Background Traumatic brain injury (TBI) causes long‐term disability, with inflammation contributing to both primary and secondary brain damage. Extracellular adenosine triphosphate (ATP) and its receptor purinergic receptor X7...
-
Issue Information
Neuroprotection, Volume 4, Issue 3, Page i-iv, September 2026.
-
Circadian rhythms and chronotherapy in Alzheimer's disease: Mechanisms and therapeutic implications
Neuroprotection, Volume 4, Issue 3, Page 229-247, September 2026.
-
Global trends in epilepsy and the Chinese experience: Epidemiological transitions, underlying mechanisms, and integrated strategies (1990–2021)
Neuroprotection, Volume 4, Issue 3, Page 199-212, September 2026.
-
Heparan sulfate and glycomimetics: Advances in synthesis and biological applications for post‐stroke neurorepair
Neuroprotection, Volume 4, Issue 3, Page 213-228, September 2026.
-
An open‐source pipeline for longitudinal single‐cell tracking and cell‐cycle/migration coupling analysis for neurotherapeutic screening
Neuroprotection, Volume 4, Issue 3, Page 295-305, September 2026.
-
Understanding neurodegeneration and regeneration in the CNS: New concepts, clinical investigations, and an unsung hero of neuroscience
Neuroprotection, Volume 4, Issue 3, Page 191-194, September 2026.
-
Could limb laterality influence the efficacy of remote postischemic conditioning after stroke?
Neuroprotection, Volume 4, Issue 3, Page 195-198, September 2026.
-
Nicolás Achúcarro: A forgotten architect of glial biology and neuroprotection
Neuroprotection, Volume 4, Issue 3, Page 306-309, September 2026.
-
Post‐Omicron cognitive decline is largely reversible: Two‐year multicenter cohort study of domain‐specific outcomes in hospitalized patients
Neuroprotection, Volume 4, Issue 3, Page 248-261, September 2026.
-
Graded traumatic brain injury severity differentially modulates microglial and astrocytic polarization states and response to minocycline
Neuroprotection, Volume 4, Issue 3, Page 275-294, September 2026.
-
Imaging patterns and genetic associations of brain atrophy across distinct symptom stages in Parkinson's disease
Neuroprotection, Volume 4, Issue 3, Page 262-274, September 2026.
-
Burden of ischemic stroke in China from 1990 to 2050: A systematic review and analysis of Global Burden of Disease Study 2021
Abstract Background Comprehensive understanding of the ischemic stroke (IS) burden in China is critical for policy and medical resource allocation. We aimed to identify the most up‐to‐date IS burden by age‐ and sex‐specific temporal...
-
Current status and future perspectives of platelet function‐guided precision antiplatelet therapy for patients with cerebral infarction
Abstract Current evidence indicates that antiplatelet therapy as a cornerstone for secondary prevention of cerebral infarction. However, ischemic or bleeding events arising from antiplatelet drug resistance or excessive platelet...
-
Serum elemental profile‐based machine learning models for Alzheimer's disease identification and cognitive score prediction
Abstract Background Current diagnostic approaches for Alzheimer's disease (AD) largely rely on cerebrospinal fluid biomarkers and neuroimaging, which may be invasive, costly, and not readily accessible in routine clinical settings. We...
-
Prime editing in neuropsychiatric disorders: From mutation‐specific target selection to clinical translation
Abstract Prime editing, a novel clustered regularly interspaced short palindromic repeats (CRISPR)‐based technology, fuses a reverse transcriptase (RT) to an engineered CRISPR‐associated protein 9 (Cas9) and uses a prime editing guide...